Welcome to the tag category page for Antibiotic!
Cefpodoxime is an oral antibiotic belonging to the third generation of cephalosporins. It is effective in treating various bacterial infections such as bronchitis, pneumonia, gonorrhea, skin infections, ear infections, sinus infections, throat infections, tonsillitis, and urinary tract infections. Cefpodoxime works by killing bacteria or preventing their growth. It is active against most Gram-positive and Gram-negative organisms, but is not effective against Pseudomonas aeruginosa, Enterococcus, and Bacteroides fragilis. Cefpodoxime may cause side effects, such as diarrhea, nausea, vomiting, stomach pain, rash, itching, or swelling. It is available as a generic medication and is considered an affordable option for treating bacterial infections.
Cefpodoxime proxetil is an oral third‑generation cephalosporin antibiotic used to treat a range of bacterial infections, including otitis media, pharyngitis, sinusitis, bronchitis, urinary tract infections, skin infections, and some sexually transmitted infections. It is a prodrug that is absorbed from the gut and de‑esterified to the active agent, cefpodoxime, which exerts bactericidal activity by inhibiting cell wall synthesis. Clinically it is valued as a broad‑spectrum outpatient option, often used in pediatric and adult respiratory and ENT infections; some studies have shown comparable or superior effectiveness to agents such as amoxicillin/clavulanate in selected settings. Common adverse effects include gastrointestinal upset, diarrhea, and hypersensitivity reactions; caution is advised in patients with a history of beta‑lactam allergy. From a market perspective, cefpodoxime is widely available as a generic, supporting cost‑sensitive prescribing, while antimicrobial stewardship and evolving resistance patterns continue to shape its use and guideline recommendations.
Clindamycin injection is a medication used to treat certain types of bacterial infections in different areas of the body. It is available in injectable and oral forms. The injectable form is administered either intravenously or intramuscularly, and must be diluted prior to administration when given intravenously. Peak serum levels are reached by the end of a short-term infusion, and within 3 hours after intramuscular injection in adults, and 1 hour for pediatric patients. Clindamycin should not be injected intravenously undiluted as a bolus. Clindamycin is in a class of medications called lincomycin antibiotics, and works by slowing or stopping the growth of bacteria. Possible side effects include nausea, vomiting, diarrhea, and abdominal pain. Clindamycin injection should not be used by people with a history of allergic reactions to the medication.
